Asia Pacific Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type, By End User, By Application, By Product Type, By Country and Growth Forecast, 2023

List of Tables

The Asia Pacific Rabies Vaccine Market would witness market growth of 5.1% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Rabies Vaccine Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $118.8 Million by 2030. The Japan market is registering a CAGR of 4.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 5.7% during (2023 - 2030).

Urbanization and encroachment into wildlife habitats can increase interactions between humans, domestic animals, and wildlife, raising the risk of dog bites. As urban areas expand and human populations grow, the potential for encountering rabies-infected animals, particularly dogs, escalates. This trend amplifies the importance of vaccination efforts to curb the spread of rabies.

There is a growing recognition of the interconnectedness of human, animal, and environmental health. The One Health approach emphasizes collaborative efforts between human and veterinary healthcare professionals, environmental scientists, and other stakeholders to address rabies at the interface of wildlife, domestic animals, and humans. This holistic perspective enhances the effectiveness of rabies control strategies by considering the complex interactions between different ecosystems.

India has a high incidence of rabies cases, and the disease is a serious public health issue. Public health awareness campaigns are crucial in educating communities about the risks of rabies and the importance of vaccination in India. Rabies control initiatives are implemented in rural and urban areas, recognizing that rabies affects populations across diverse settings in India. The One Health approach, recognizing the interconnectedness of human, animal, and environmental health, is applied in rabies control efforts in India. As per a report published by the Ministry of Health and Family Welfare Government of India, dog-mediated rabies is responsible for an estimated 35172 human deaths (59.6% of global deaths) and 2.2 million disability-adjusted life years (DALYs) lost annually in Asia in 2022. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.

Based on Prophylaxis Type, the market is segmented into Post-exposure Prophylaxis, and Pre-exposure prophylaxis. Based on End User, the market is segmented into Hospitals, Veterinary Clinics, and Others. Based on Application, the market is segmented into Human, and Animal. Based on Product Type, the market is segmented into Chick Embryo Cells Rabies Vaccine, Human Diploid Cell Vaccine, Vero cell rabies vaccine, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

Boehringer Ingelheim International GmbH
Cadila Pharmaceuticals Limited
Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
Elanco Animal Health, Inc.
Zoetis, Inc.
Merck & Co., Inc.
Novartis AG
Bharat Biotech Ltd.
Sanofi S.A.
Virbac

Asia Pacific Rabies Vaccine Market Report Segmentation

By Prophylaxis Type

Post-exposure Prophylaxis
Pre-exposure prophylaxis

By End User

Hospitals
Veterinary Clinics
Others

By Application

Human
Animal

By Product Type

Chick Embryo Cells Rabies Vaccine
Human Diploid Cell Vaccine
Vero cell rabies vaccine
Others

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Asia Pacific Rabies Vaccine Market, by Prophylaxis Type
- 1.4.2Asia Pacific Rabies Vaccine Market, by End User
- 1.4.3Asia Pacific Rabies Vaccine Market, by Application
- 1.4.4Asia Pacific Rabies Vaccine Market, by Product Type
- 1.4.5Asia Pacific Rabies Vaccine Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.Asia Pacific Rabies Vaccine Market by Prophylaxis Type

4.1Asia Pacific Post-exposure Prophylaxis Market by Country
4.2Asia Pacific Pre-exposure prophylaxis Market by Country

Chapter 5.Asia Pacific Rabies Vaccine Market by End User

5.1Asia Pacific Hospitals Market by Country
5.2Asia Pacific Veterinary Clinics Market by Country
5.3Asia Pacific Others Market by Country

Chapter 6.Asia Pacific Rabies Vaccine Market by Application

6.1Asia Pacific Human Market by Country
6.2Asia Pacific Animal Market by Country

Chapter 7.Asia Pacific Rabies Vaccine Market by Product Type

7.1Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country
7.2Asia Pacific Human Diploid Cell Vaccine Market by Country
7.3Asia Pacific Vero Cell Rabies Vaccine Market by Country
7.4Asia Pacific Others Market by Country

Chapter 8.Asia Pacific Rabies Vaccine Market by Country

8.1China Rabies Vaccine Market
- 8.1.1China Rabies Vaccine Market by Prophylaxis Type
- 8.1.2China Rabies Vaccine Market by End User
- 8.1.3China Rabies Vaccine Market by Application
- 8.1.4China Rabies Vaccine Market by Product Type
8.2Japan Rabies Vaccine Market
- 8.2.1Japan Rabies Vaccine Market by Prophylaxis Type
- 8.2.2Japan Rabies Vaccine Market by End User
- 8.2.3Japan Rabies Vaccine Market by Application
- 8.2.4Japan Rabies Vaccine Market by Product Type
8.3India Rabies Vaccine Market
- 8.3.1India Rabies Vaccine Market by Prophylaxis Type
- 8.3.2India Rabies Vaccine Market by End User
- 8.3.3India Rabies Vaccine Market by Application
- 8.3.4India Rabies Vaccine Market by Product Type
8.4South Korea Rabies Vaccine Market
- 8.4.1South Korea Rabies Vaccine Market by Prophylaxis Type
- 8.4.2South Korea Rabies Vaccine Market by End User
- 8.4.3South Korea Rabies Vaccine Market by Application
- 8.4.4South Korea Rabies Vaccine Market by Product Type
8.5Singapore Rabies Vaccine Market
- 8.5.1Singapore Rabies Vaccine Market by Prophylaxis Type
- 8.5.2Singapore Rabies Vaccine Market by End User
- 8.5.3Singapore Rabies Vaccine Market by Application
- 8.5.4Singapore Rabies Vaccine Market by Product Type
8.6Malaysia Rabies Vaccine Market
- 8.6.1Malaysia Rabies Vaccine Market by Prophylaxis Type
- 8.6.2Malaysia Rabies Vaccine Market by End User
- 8.6.3Malaysia Rabies Vaccine Market by Application
- 8.6.4Malaysia Rabies Vaccine Market by Product Type
8.7Rest of Asia Pacific Rabies Vaccine Market
- 8.7.1Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type
- 8.7.2Rest of Asia Pacific Rabies Vaccine Market by End User
- 8.7.3Rest of Asia Pacific Rabies Vaccine Market by Application
- 8.7.4Rest of Asia Pacific Rabies Vaccine Market by Product Type

Chapter 9.Company Profiles

9.1Cadila Pharmaceuticals Limited
- 9.1.1Company Overview
- 9.1.2Recent strategies and developments:
  - 9.1.2.1Product Launches and Product Expansions:
9.2Bharat Biotech Ltd.
- 9.2.1Company Overview
9.3Serum Institute of India Pvt. Ltd. (Cyrus Poonawalla Group)
- 9.3.1Company Overview
9.4Boehringer Ingelheim International GmbH
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional & Segmental Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
9.5Elanco Animal Health, Inc.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5SWOT Analysis
9.6Zoetis, Inc.
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
9.7Merck & Co., Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Segmental and Regional Analysis
- 9.7.4Research & Development Expenses
- 9.7.5SWOT Analysis
9.8Novartis AG
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Segmental and Regional Analysis
- 9.8.4Research & Development Expense
- 9.8.5SWOT Analysis
9.9Sanofi S.A.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental and Regional Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
9.10.Virbac
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4SWOT Analysis

LIST OF TABLES

TABLE 1Asia Pacific Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 2Asia Pacific Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 3Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 4Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 5Asia Pacific Post-exposure Prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 6Asia Pacific Post-exposure Prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 7Asia Pacific Pre-exposure prophylaxis Market by Country, 2019 - 2022, USD Million
TABLE 8Asia Pacific Pre-exposure prophylaxis Market by Country, 2023 - 2030, USD Million
TABLE 9Asia Pacific Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 10Asia Pacific Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 11Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 12Asia Pacific Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 13Asia Pacific Veterinary Clinics Market by Country, 2019 - 2022, USD Million
TABLE 14Asia Pacific Veterinary Clinics Market by Country, 2023 - 2030, USD Million
TABLE 15Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 16Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 17Asia Pacific Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 18Asia Pacific Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 19Asia Pacific Human Market by Country, 2019 - 2022, USD Million
TABLE 20Asia Pacific Human Market by Country, 2023 - 2030, USD Million
TABLE 21Asia Pacific Animal Market by Country, 2019 - 2022, USD Million
TABLE 22Asia Pacific Animal Market by Country, 2023 - 2030, USD Million
TABLE 23Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 24Asia Pacific Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 25Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 26Asia Pacific Chick Embryo Cells Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 27Asia Pacific Human Diploid Cell Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 28Asia Pacific Human Diploid Cell Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 29Asia Pacific Vero Cell Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 30Asia Pacific Vero Cell Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 31Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 32Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 33Asia Pacific Rabies Vaccine Market by Country, 2019 - 2022, USD Million
TABLE 34Asia Pacific Rabies Vaccine Market by Country, 2023 - 2030, USD Million
TABLE 35China Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 36China Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 37China Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 38China Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 39China Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 40China Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 41China Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 42China Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 43China Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 44China Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 45Japan Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 46Japan Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 47Japan Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 48Japan Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 49Japan Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 50Japan Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 51Japan Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 52Japan Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 53Japan Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 54Japan Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 55India Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 56India Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 57India Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 58India Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 59India Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 60India Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 61India Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 62India Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 63India Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 64India Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 65South Korea Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 66South Korea Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 67South Korea Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 68South Korea Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 69South Korea Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 70South Korea Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 71South Korea Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 72South Korea Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 73South Korea Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 74South Korea Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 75Singapore Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 76Singapore Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 77Singapore Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 78Singapore Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 79Singapore Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 80Singapore Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 81Singapore Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 82Singapore Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 83Singapore Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 84Singapore Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 85Malaysia Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 86Malaysia Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 87Malaysia Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 88Malaysia Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 89Malaysia Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 90Malaysia Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 91Malaysia Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 92Malaysia Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 93Malaysia Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 94Malaysia Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 95Rest of Asia Pacific Rabies Vaccine Market, 2019 - 2022, USD Million
TABLE 96Rest of Asia Pacific Rabies Vaccine Market, 2023 - 2030, USD Million
TABLE 97Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2019 - 2022, USD Million
TABLE 98Rest of Asia Pacific Rabies Vaccine Market by Prophylaxis Type, 2023 - 2030, USD Million
TABLE 99Rest of Asia Pacific Rabies Vaccine Market by End User, 2019 - 2022, USD Million
TABLE 100Rest of Asia Pacific Rabies Vaccine Market by End User, 2023 - 2030, USD Million
TABLE 101Rest of Asia Pacific Rabies Vaccine Market by Application, 2019 - 2022, USD Million
TABLE 102Rest of Asia Pacific Rabies Vaccine Market by Application, 2023 - 2030, USD Million
TABLE 103Rest of Asia Pacific Rabies Vaccine Market by Product Type, 2019 - 2022, USD Million
TABLE 104Rest of Asia Pacific Rabies Vaccine Market by Product Type, 2023 - 2030, USD Million
TABLE 105Key Information - Cadila Pharmaceuticals Limited
TABLE 106Key Information - Bharat Biotech Ltd.
TABLE 107Key Information - Serum Institute of India Pvt. Ltd.
TABLE 108Key Information - Boehringer Ingelheim International GmbH
TABLE 109Key information - Elanco Animal Health, Inc.
TABLE 110Key Information - Zoetis, Inc.
TABLE 111Key Information - Merck & Co., Inc.
TABLE 112Key Information - Novartis AG
TABLE 113Key Information - Sanofi S.A.
TABLE 114Key Information - Virbac

Asia Pacific Rabies Vaccine Market Size, Share & Trends Analysis Report By Prophylaxis Type, By End User, By Application, By Product Type, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents